Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 6, 2010MedChemComm

Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYen‐Ting ChenNational Taiwan UniversityTVTomáš VojkovskýOkinawa Institute of Science and Technology Graduate UniversityXFX. M. FangFlorida State University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2010) studied this question.

synapsesocial.com/papers/6aa63833fff38ca398dd46c4https://doi.org/10.1039/c0md00194e
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage1992 · 475 citations
  2. 2Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase2007 · 65 citations
  3. 3ROCK‐I and ROCK‐II, two isoforms of Rho‐associated coiled‐coil forming protein serine/threonine kinase in mice1996 · 807 citations
  4. 4Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor2009 · 88 citations